A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: Efficacy and safety

ANIL YAĞCIOĞLU A. E., Akdede B. B., Turgut T., Tumuklu M., YAZICI M. K., ALPTEKİN K., ...Daha Fazla

JOURNAL OF CLINICAL PSYCHIATRY, cilt.66, sa.1, ss.63-72, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 66 Sayı: 1
  • Basım Tarihi: 2005
  • Doi Numarası: 10.4088/jcp.v66n0109
  • Dergi Adı: JOURNAL OF CLINICAL PSYCHIATRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Sayfa Sayıları: ss.63-72
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Several open trials and case studies have reported beneficial effects following the addition of risperidone for partial responders to clozapine. The purpose of this study was to carry out a placebo-controlled, randomized. double-blind trial of the efficacy, safety, and tolerability of adjunctive treatment with risperidone in patients with schizophrenia partially responsive to clozapine.